These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3959820)

  • 1. [Determination of calcitonin and parathyrin in blood serum in the diagnosis of tumor metastases to bone].
    Smirnov IuN
    Med Radiol (Mosk); 1986 Apr; 31(4):9-12. PubMed ID: 3959820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcitonin and parathyrin in the blood serum of cancer patients].
    Tkacheva GA; Kirsanov AG; Burenin IS
    Vopr Onkol; 1982; 28(7):49-55. PubMed ID: 7101829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circadian rhythm of parathyrin and calcitonin concentrations in the serum].
    Radjaipour M; Kindtner E; Rösler H; Eggstein M
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):175-8. PubMed ID: 3711800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcitonin. III. Use of serum calcitonin as a tumor marker in breast and pulmonary neoplasms].
    Gadesberg CC; Nielsen HE; Olsen KJ; Hansen HH
    Ugeskr Laeger; 1979 Oct; 141(40):2744-6. PubMed ID: 531963
    [No Abstract]   [Full Text] [Related]  

  • 5. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioimmunological methods in the diagnosis of metastases of thyroid cancer].
    Lozinskaia IN; Vikman IaE
    Med Radiol (Mosk); 1987 Jun; 32(6):6-9. PubMed ID: 3600228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone and calcitonin in serum of patients with mammary carcinoma.
    Rasmusson B; Roesdahl K; Lindgreen P
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(4):269-76. PubMed ID: 717040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Main indicators of hormonal status in lung diseases].
    Zyrianov BN; Velichko SA; Kuznetsov VV; Siianov VS
    Med Radiol (Mosk); 1988 Aug; 33(8):31-4. PubMed ID: 2842572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
    Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
    Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the lung: relation of calcitonin to bone marrow metastases, parathormone and gastrin.
    Hansen M; Rehfeld JF; Stadil F
    Acta Med Scand; 1979; 206(3):215-8. PubMed ID: 227233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoreactive serum calcitonin in breast cancer].
    Fereberger W; Leb G; Passath A; Samonigg H; Beaufort F
    MMW Munch Med Wochenschr; 1982 May; 124(19):471-2. PubMed ID: 6810110
    [No Abstract]   [Full Text] [Related]  

  • 15. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
    Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunologic determination of plasma parathormone in hypercalcemia caused by cancer with osseous metastases].
    Lemaire V; Gueris J; Cassou M; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):709-13. PubMed ID: 609875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of procollagen type 1 amino-terminal propeptide in patients with renal cell carcinoma.
    Klepzig M; Sauer-Eppel H; Jonas D; Oremek GM
    Anticancer Res; 2008; 28(4C):2443-6. PubMed ID: 18751432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
    Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
    Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The measurement of calcium-regulating hormones in clinical medicine.
    Posen S; Clifton-Bligh P; Mason RS
    Prog Biochem Pharmacol; 1980; 17():220-7. PubMed ID: 7208501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.